Craniofacial Effects of Zoledronic Acid on the Osteogenesis Imperfecta Mouse (−/−) Model of Severe Osteogenesis Imperfecta
<b>Background:</b> Osteogenesis imperfecta (OI) is a rare genetic disorder affecting mainly type I collagen, which leads to bone fragility and deformities. OI patients also present craniofacial abnormalities such as macrocephaly and malocclusion. Recently, craniofacial dysmorphism was hi...
Saved in:
Main Authors: | Gaspard Jeannerod, Antoine Chretien, Grégoire André, Guillaume Mabilleau, Catherine Behets |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-11-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/12/2692 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Biphosphonates in Patients with Osteogenesis Imperfecta
by: Erdal Eren, et al.
Published: (2011-12-01) -
Respiratory insufficiency in an infant with osteogenesis imperfecta
by: Adeline Yi Ling Lim, et al.
Published: (2024-01-01) -
HRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
by: Tri Wahyu Martanto, et al.
Published: (2023-10-01) -
Retrospective Evaluation of Patients Diagnosed with Osteogenesis Imperfecta
by: Mustafa Törehan Aslan, et al.
Published: (2017-01-01) -
Evaluation of Radiolucent Lesions in Cortices of Long Bones in Osteogenesis Imperfecta Patients
by: Carolyn Cook, MD, et al.
Published: (2024-11-01)